Analysing lithium, quetiapine and valproic acid on social media: an infodemiology study

Despite lithium being the least mentioned drug, it generated the highest level of engagement, particularly among healthcare professionals. In contrast, quetiapine was widely mentioned by patients, which reflects a more socially widespread and, at times, problematic use. These findings highlight the value of listening to conversations on social media to better understand perceptions, concerns, and attitudes that may influence adherence and prescribing trends in mental health.

Authors

Institutions

Publication Details

Journal
International Journal of Bipolar Disorders
Published
2025-10-24
DOI
https://doi.org/10.1186/s40345-025-00395-6
Citations
1
Primary Topic
Bipolar Disorder and Treatment
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysing lithium, quetiapine and valproic acid on social media: an infodemiology study

Roberto Rodríguez–Jiménez, César I. Fernández-Lázaro, Ana González‐Pinto, Íñigo Alberdi‐Páramo et al.
1 citations
International Journal of Bipolar Disorders
Bipolar Disorder and Treatment
1.47
article

Analysing lithium, quetiapine and valproic acid on social media: an infodemiology study

Roberto Rodríguez–Jiménez, César I. Fernández-Lázaro, Ana González‐Pinto, Íñigo Alberdi‐Páramo, Juan Pablo Chart‐Pascual, Raquel Martínez-Velasco, María Montero-Torres, Francisco J. Lara-Abelenda, Miguel Ángel Alvarez‐Mon, Julen Marin-Napal
article en
1 citations

Abstract

Despite lithium being the least mentioned drug, it generated the highest level of engagement, particularly among healthcare professionals. In contrast, quetiapine was widely mentioned by patients, which reflects a more socially widespread and, at times, problematic use. These findings highlight the value of listening to conversations on social media to better understand perceptions, concerns, and attitudes that may influence adherence and prescribing trends in mental health.

International Journal of Bipolar DisordersVol. 13(1)
Universidad Complutense de Madrid (ES), University of the Basque Country (ES), Universidad Rey Juan Carlos (ES), King's College London (GB), Universidad de Alcalá (ES), Instituto Cajal (ES), Hospital Clínico San Carlos (ES), Research Institute Hospital 12 de Octubre (ES), BioCruces Health research Institute (ES), Centro de Investigación Biomédica en Red de Salud Mental (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Universitario Araba (ES), Navarre Institute of Health Research (ES), Osakidetza (ES), Instituto Ramón y Cajal de Investigación Sanitaria (ES), Centro de Tecnologías Aeronauticas (Spain) (ES), Universidad de Navarra (ES)
Fundación Alicia Koplowitz, Comunidad de Madrid, Eusko Jaurlaritza, Instituto de Salud Carlos III
Openalex Percentile: Top 14%
Bipolar Disorder and Treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.